NEW YORK (GenomeWeb News) – Foundation Medicine reported after the close of the market Wednesday that its third quarter revenues more than doubled year over year and were up 39 percent over the second quarter of this year.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $8.2 million for the three months ended Sept. 30, up from $3 million in Q3 2012 and $5.9 million in Q2 2013. It beat the consensus Wall Street estimate for revenues of $6.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.